Sign In
Section Navigation
Common TitleDRIVE BEYOND
Official Title A Phase IIa Multicenter, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of Doravirine-Tenofovir disoproxil fumarate-Lamivudine (MK-1439A) in Treatment-Naïve HIV-1 Infected Subjects With Selected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Transmitted Resistance Mutations
Phase Phase IIA
ClinicalTrials.gov NCT02629822
Funding
IndustryMerck

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.